Press Releases Drägerwerk AG & Co. KGaA London S.E.

Equities

0K5E

DE0005550636

Real-time Estimate Tradegate Other stock markets 14:41:37 17/06/2024 BST			5-day change	1st Jan Change
50.75 ^EUR	-0.59%		+1.75%	-2.91%

05-23	Ailing hospitals slow down German medical technology sector	DP
05-01	DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility	05-08	EQ
Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase	05-08	EQ
Drägerwerk : Transcript Report for the first quarter of 2024	04-28	PU
Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024	04-25	EQ
Drägerwerk : Capital markets presentation for the first quarter 2024	04-24	PU
Drägerwerk : Ad hoc notification for the first quarter of 2024	04-24	PU
Drägerwerk : Presentation for the first quarter of 2024	04-24	PU
Drägerwerk : Report for the first quarter of 2024	04-24	PU
Drägerwerk : Press release for the first quarter of 2024	04-24	PU
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed	04-15	EQ
Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend	03-07	EQ
Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024	01-15	EQ
Drägerwerk AG & Co. KGaA: Annual forecast raised again	12-13	EQ
Drägerwerk AG & Co. KGaA: Annual forecast raised again	12-13	EQ
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052	11-20	EQ
DD: Drägerwerk AG & Co. KGaA: Anton Schrofner, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price ...	11-14	EQ
DD: Drägerwerk AG & Co. KGaA: Gert-Hartwig Lescow, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the ...	11-13	EQ
DD: Drägerwerk AG & Co. KGaA: Stefan Dräger, Purchase under the employee participation program: The terms and conditions of the employee participation program stipulate that, if the price ...	11-09	EQ
Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023	11-02	EQ
Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised	16/10/23	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DRÄGERWERK AG & CO KGAA : China weighs on Q1 24 growth

May 01, 2024 at 05:40 pm